.png)
Management Behind Alzex Neupharma Inc.

Dr. Francis Marsais
Dr. Marsais is the Founder and President of VFP Therapies based in Rouen France. He holds a doctorate in Organic Chemistry and has over 30 years of experience in research and development of molecular compounds for the treatment of degenerative brain diseases. Dr. Marsais was the Managing Director of the Institut de Recherche en Chimie Organique Fine (IRCOF) from 1997 to 2010. He was also the Director in charge of partnerships at INSA, Institut National des Sciences Appliquées, a major French academic engineer and research institute, from 2007 to 2011. He is credited with over 130 publications and articles, 5 patents and has been a supervisor of more than 30 doctoral thesis. Dr. Marsais is currently Professor Emeritus, President of VFP-Therapies S.A.S.

Dr. Fabrice Heitzmann
Dr. Marsais is the Founder and President of VFP Therapies based in Rouen France. He holds a doctorate in Organic Chemistry and has over 30 years of experience in research and development of molecular compounds for the treatment of degenerative brain diseases. Dr. Marsais was the Managing Director of the Institut de Recherche en Chimie Organique Fine (IRCOF) from 1997 to 2010. He was also the Director in charge of partnerships at INSA, Institut National des Sciences Appliquées, a major French academic engineer and research institute, from 2007 to 2011. He is credited with over 130 publications and articles, 5 patents and has been a supervisor of more than 30 doctoral thesis. Dr. Marsais is currently Professor Emeritus, President of VFP-Therapies S.A.S.
.png)
Christophe Clément
Dr. Marsais is the Founder and President of VFP Therapies based in Rouen France. He holds a doctorate in Organic Chemistry and has over 30 years of experience in research and development of molecular compounds for the treatment of degenerative brain diseases. Dr. Marsais was the Managing Director of the Institut de Recherche en Chimie Organique Fine (IRCOF) from 1997 to 2010. He was also the Director in charge of partnerships at INSA, Institut National des Sciences Appliquées, a major French academic engineer and research institute, from 2007 to 2011. He is credited with over 130 publications and articles, 5 patents and has been a supervisor of more than 30 doctoral thesis. Dr. Marsais is currently Professor Emeritus, President of VFP-Therapies S.A.S.
.webp)